β-受体阻滞剂治疗慢性充血性心衰伴房颤疗效分析  

The efficacy of β-receptor blocker in the treatment of congestive heart failure with atrial fibrillation.

作　　者：陈爱武[1] 李珂[1] 霍垚[1] 鲁跃华[1] 

机构地区：[1]成都铁路局中心医院,四川成都610081

出　　处：《四川医学》2002年第3期240-241,共2页Sichuan Medical Journal

摘　　要：目的　观察β-受体阻滞剂治疗慢性充血性心衰 ( CHF)伴房颤的疗效。方法　将 10 5例器质性心脏病、CHF伴快速持续性房颤患者分为治疗组 5 5例 ,用常规抗心衰治疗加氨酰心安治疗 4 wk。对照组 5 0例 ,单用常规抗心衰治疗4 wk。结果　治疗组在减慢心率、改善心功、降低病死率方面均优于对照组 ,总有效率分别为 81.8%和 5 0 % ,病死率分别为1.8%和 14 % ,两组间有显著性差别 ,P<0 .0 5。结论　在常规抗心衰治疗基础上加用β-受体阻滞剂 ,可明显降低心率、改善心功 ,提高生活质量 。Objective To observe the efficacy of β receptor blocker in the treatment of congestive heart failure(CHF)with atrial fibrillation.Methods One hundred and five cases of rapid atrial fibrillation with organic heart disease and CHF were divided into treatment group and comparison group.The treatment group,55 cases,received the routine CHF treatment with the addition of β receptor blocker for 4 weeks. The comparison group,50 cases,received the routine CHF treatment.Results The treatment group had better results in decreasing heart rate,improving heart function and decreasing mortality rate than the comparison group.In the treatment group,the efficacy rate was 81.8%,and mortality rate 1.8%.In the comparison group,the efficacy rate was 50%,and the mortality rate 14%.Significant differences in the efficacy rate and mortality rate between the two groups were noted, P <0 05.Conclusion The use of β receptor blocker on the basis of routine CHF treatment may lower the heart rate,improve the heart function,better the quality of life,and decrease the rehospitalization rate and mortality rate.

关 键 词：慢性充血性心力衰竭 房颤 药物疗法 Β-受体阻滞剂 治疗 疗效 

分 类 号：R541.61[医药卫生—心血管疾病] R541.75[医药卫生—内科学]